Senti Biosciences Debt To Equity vs. Total Asset
| SNTI Stock | USD 2.17 0.05 2.36% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter 0.0141 | Current Value 0.0125 | Quarterly Volatility 0.00087092 |
For Senti Biosciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Senti Biosciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Senti Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Senti Biosciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Senti Biosciences over time as well as its relative position and ranking within its peers.
Senti |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Senti Biosciences. If investors know Senti will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Senti Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.59) | Revenue Per Share 0.075 | Quarterly Revenue Growth (1.00) | Return On Assets (0.33) | Return On Equity (1.11) |
The market value of Senti Biosciences is measured differently than its book value, which is the value of Senti that is recorded on the company's balance sheet. Investors also form their own opinion of Senti Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Senti Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Senti Biosciences' market value can be influenced by many factors that don't directly affect Senti Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Senti Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Senti Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Senti Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Senti Biosciences Total Asset vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Senti Biosciences's current stock value. Our valuation model uses many indicators to compare Senti Biosciences value to that of its competitors to determine the firm's financial worth. Senti Biosciences is rated fifth in debt to equity category among its peers. It is rated below average in total asset category among its peers fabricating about 597,420,000 of Total Asset per Debt To Equity. As of now, Senti Biosciences' Debt To Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Senti Biosciences' earnings, one of the primary drivers of an investment's value.Senti Total Asset vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Senti Biosciences |
| = | 0.20 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Senti Biosciences |
| = | 119.48 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Senti Total Asset Comparison
Senti Biosciences is currently under evaluation in total asset category among its peers.
Senti Biosciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Senti Biosciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Senti Biosciences will eventually generate negative long term returns. The profitability progress is the general direction of Senti Biosciences' change in net profit over the period of time. It can combine multiple indicators of Senti Biosciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -119.5 M | -125.5 M | |
| Operating Income | -92.7 M | -88.1 M | |
| Income Before Tax | -83.4 M | -79.2 M | |
| Total Other Income Expense Net | 9.3 M | 9.8 M | |
| Net Loss | -52.4 M | -55 M | |
| Net Loss | -71.1 M | -74.6 M | |
| Net Interest Income | 3.6 M | 3.7 M | |
| Interest Income | 3.6 M | 3.7 M | |
| Net Loss | -88.3 M | -92.7 M | |
| Income Tax Expense | 9.5 M | 10 M | |
| Non Operating Income Net Other | 9.6 M | 8.6 M | |
| Change To Netincome | 6.5 M | 5 M | |
| Net Loss | (20.94) | (21.99) | |
| Income Quality | 0.74 | 0.89 | |
| Net Income Per E B T | 1.00 | 0.89 |
Senti Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Senti Biosciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Senti Biosciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Senti Biosciences' important profitability drivers and their relationship over time.
Use Senti Biosciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Senti Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Senti Biosciences will appreciate offsetting losses from the drop in the long position's value.Senti Biosciences Pair Trading
Senti Biosciences Pair Trading Analysis
The ability to find closely correlated positions to Senti Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Senti Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Senti Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Senti Biosciences to buy it.
The correlation of Senti Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Senti Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Senti Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Senti Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Senti Biosciences position
In addition to having Senti Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Recreation theme has 33 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
To fully project Senti Biosciences' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Senti Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Senti Biosciences' income statement, its balance sheet, and the statement of cash flows.